º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

North East deals of the week: key contracts, investments and acquisitions

Companies in this week's round-up include JLM Global Foods, Ensus, LightOx, NunaBio, Magnitude Biosciences, Hexis Lab, Jump, Fabric Academy and Panelbase

Dr Stephan Meeder, CEO and CFO of CropEnergies AG (left) with Grant Pearson, chairman of Ensus º£½ÇÊÓÆµ examining the animal feed currently produced at the Ensus plant.(Image: Ensus)

Bioethanol maker Ensus º£½ÇÊÓÆµ revealed plans to invest around £90m into its Teesside operations.

The Wilton International firm's German parent company - CropEnergies AG - will invest in a series of projects at the site - the largest of which will be the creation of a new high protein animal feed manufacturing unit. Smaller sums will be spent on upgrades to improve plant reliability and energy efficiency.

No new jobs are expected to be created in the moves, but the firm indicated Ensus º£½ÇÊÓÆµ's 100-strong workforce will be sustained by the plans. The plant is one of Europe's largest production sites for bioenthanol - a road fuel - which has two key by-products in enriched animal feed and biogenic CO2 used by the food and drink industry.

Between £60m to £70m will be spent on the new animal feed facility which could start production in 2025. It will allow the firm to produce EnPro, a high-protein product aimed at º£½ÇÊÓÆµ and European aquafeed and pet food markets.

Ensus said it builds on its position as the º£½ÇÊÓÆµ's largest producer of protein animal feed to farmers. The Redcar plant currently produces about 350,000 tonnes per year of protein enriched dried distillers' grains with solubles, aimed at the º£½ÇÊÓÆµ cattle and pig farming industry.

From left to right: Prof Carrie Ambler, (LightOx) Dr Sam Whitehouse (LightOx), Dr Fozia Saleem (Magnitude Biosciences), Chi Onwurah (Labour MP and Shadow Minister for Science Research and Digital), Olusola (Sola) Idowu (Hexis Lab), Dr Andrew Pike (NunaBio)(Image: LightOx Ltd)

Four North East life science and biomedical pioneers are set to scale up their growth plans after securing grants totalling more than £2.5m.

Newcastle based LightOx, NunaBio, Magnitude Biosciences and Hexis Lab have received the funds from Innovate º£½ÇÊÓÆµ’s latest round of R&D grants, which are designed to help accelerate their growth and leverage private sector investment in the region.

The funding will be used to advance the pharmaceutical and biotechnology research services, technology and drug development of the companies. In all, Innovate º£½ÇÊÓÆµ – part of º£½ÇÊÓÆµ Research and Innovation – has invested up to £25m in a range of projects across the country this year, supporting businesses developing solutions to tackle significant health or healthcare challenges.